2 massive drugmakers are locked in a battle over the market for cancer immunotherapy — Goldman analysts say one is pulling ahead

  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 51%

Australia News News

Australia Australia Latest News,Australia Australia Headlines

Pharma giants Merck and Bristol-Myers Squibb are fighting for dominance in the multi-billion dollar cancer immunotherapy market.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 729. in AU
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Behind pay wall.. nice trick

Australia Australia Latest News, Australia Australia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Marijuana stocks to watch: Meet the drugmaker making cannabis-based medicines for autism, cancer and moreDrugmakers commonly make their medicines synthetically — think a lab, not a greenhouse. But because its medications employ cannabinoids, the U.K.-based GW Pharma also grows it own cannabis plants.
Source: MarketWatch - 🏆 3. / 97 Read more »

Pharma Industry Pushes Back Against Required Listing of Drug Prices in TV AdsThe pharmaceutical industry is signaling resistance to a Trump administration plan to require that the list price be included for most drugs in television ads, setting the stage for a protracted fight over a proposal with broad bipartisan support. JUST MAKE IT LAW, THEY HAVE THE MONEY. What could be wrong with this? Pharma, why are you upset with telling consumers how much you are going to cost? Is it that you are worried that we will be pissed off with price gouging like the Epi-pen CEO did? Truth in advertising, what a concept!
Source: WSJ - 🏆 98. / 63 Read more »